Cargando…

Serum anti-Müllerian hormone levels are associated with perinatal outcomes in women undergoing IVF/ICSI: A multicenter retrospective cohort study

INTRODUCTION: Anti-Müllerian hormone (AMH) level has long been considered as a serum biomarker of ovarian reserve clinically, while emerging data suggest that serum AMH level may also predict pregnancy outcomes. However, whether pregestational serum AMH levels are related to perinatal outcomes among...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Yi-Chen, Su, Kai-Zhen, Cai, Jie, Meng, Qing-Xia, Wu, Yan-Ting, Huang, He-Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990865/ https://www.ncbi.nlm.nih.gov/pubmed/36896183 http://dx.doi.org/10.3389/fendo.2023.1081069

Ejemplares similares

Anti-mullerian and androgens hormones in women with polycystic ovary syndrome undergoing IVF/ICSI
por: Swellam, Menha, et al.
Publicado: (2013)

High Serum Anti-Müllerian Hormone Concentrations Are Associated With Poor Pregnancy Outcome in Fresh IVF/ICSI Cycle but Not Cumulative Live Birth Rate in PCOS Patients
por: Guo, Yaxin, et al.
Publicado: (2021)

Serum anti-Müllerian hormone levels are associated with early miscarriage in the IVF/ICSI fresh cycle
por: Liu, Xin, et al.
Publicado: (2022)

The role of serum vitamin D in patients with normal ovarian reserve undergoing the first IVF/ICSI cycle
por: Luo, Rong, et al.
Publicado: (2023)

Influencing of serum inflammatory factors on IVF/ICSI outcomes among PCOS patients with different BMI
por: He, Yilei, et al.
Publicado: (2023)

Anti-müllerian Hormone for the Prediction of Ovarian Response in Progestin-Primed Ovarian Stimulation Protocol for IVF
por: Huang, Jialyu, et al.
Publicado: (2019)

25(OH)VitD and human endocrine and functional fertility parameters in women undergoing IVF/ICSI
por: Tian, Mei, et al.
Publicado: (2022)

The Relationship Between Serum Delta FSH Level and Ovarian Response in IVF/ICSI Cycles
por: Hu, Linli, et al.
Publicado: (2020)

The predictability of serum anti-Müllerian level in IVF/ICSI outcomes for patients of advanced reproductive age
por: Lee, Robert KK, et al.
Publicado: (2011)

Efficacy of dehydroepiandrosterone priming in women with poor ovarian response undergoing IVF/ICSI: a meta-analysis
por: Zhang, Jie, et al.
Publicado: (2023)

The Effect of Endometrial Thickness on Pregnancy, Maternal, and Perinatal Outcomes of Women in Fresh Cycles After IVF/ICSI: A Systematic Review and Meta-Analysis
por: Liao, Zhiqi, et al.
Publicado: (2022)

Pregnancy and Perinatal Outcomes of Patients With Prior Cesarean Section After a Single Embryo Transfer in IVF/ICSI: A Retrospective Cohort Study
por: Wang, Lin, et al.
Publicado: (2022)

The Effects of Adiponectin on Infertile Women Undergoing IVF/ICSI Treatment and on Human Granulosa Cells
por: Qin, Lixian, et al.
Publicado: (2021)

Effect of a 60-day weight reduction intervention prior to IVF/ICSI on perinatal outcomes in overweight or obese infertile women
por: Yang, Chen, et al.
Publicado: (2022)

Factors Associated with Ovarian Hyperstimulation Syndrome (OHSS) Severity in Women With Polycystic Ovary Syndrome Undergoing IVF/ICSI
por: Sun, Bo, et al.
Publicado: (2021)

Impact of growth hormone on IVF/ICSI outcomes and endometrial receptivity of patients undergoing GnRH antagonist protocol with fresh embryo transfer: a pilot study
por: Chu, Yifan, et al.
Publicado: (2023)

High anti-Müllerian hormone levels might not reflect the likelihood of clinical pregnancy rate in IVF/ICSI treatment
por: Sun, Tie-Cheng, et al.
Publicado: (2021)

Effect of BMI on the value of serum progesterone to predict clinical pregnancy outcome in IVF/ICSI cycles: a retrospective cohort study
por: Shen, Zhaoyang, et al.
Publicado: (2023)

Analysis of IVF/ICSI Outcomes in Endometriosis Patients With Recurrent Implantation Failure: Influence on Cumulative Live Birth Rate
por: Zhong, Chenyi, et al.
Publicado: (2021)

Ovarian Endometrioma Negatively Impacts Oocyte Quality and Quantity But Not Pregnancy Outcomes in Women Undergoing IVF/ICSI Treatment: A Retrospective Cohort Study
por: Wu, Yaoqiu, et al.
Publicado: (2021)

Gonadotrophin releasing hormone antagonist in IVF/ICSI
por: MS, Kamath, et al.
Publicado: (2008)

Anti-Müllerian Hormone and OPU-ICSI Outcome in the Mare
por: Papas, Marion, et al.
Publicado: (2021)

Homeostatic Model Assessment for Insulin Resistance Is Associated With Late Miscarriage in Non-Dyslipidemic Women Undergoing Fresh IVF/ICSI Embryo Transfer
por: Yang, Tianli, et al.
Publicado: (2022)

Nomogram for predicting the risk of preterm delivery after IVF/ICSI treatment: an analysis of 11513 singleton births
por: Liao, Zhiqi, et al.
Publicado: (2023)

Assessment of the relationship of basal serum anti-mullerian hormone levels with oocyte quality and pregnancy outcomes in patients undergoing ICSI
por: Aydın, Gültekin Adanaş, et al.
Publicado: (2015)

Development and Validation of a Clinical Pregnancy Failure Prediction Model for Poor Ovarian Responders During IVF/ICSI
por: Li, Fangyuan, et al.
Publicado: (2021)

Anti-Müllerian Hormone Signal Transduction involved in Müllerian Duct Regression
por: Cate, Richard L.
Publicado: (2022)

Independent value of PMOI on hCG day in predicting pregnancy outcomes in IVF/ICSI cycles
por: Sun, Xingyu, et al.
Publicado: (2023)

Impact of Gonadotropin-Releasing Hormone Agonist Pre-treatment on the Cumulative Live Birth Rate in Infertile Women With Adenomyosis Treated With IVF/ICSI: A Retrospective Cohort Study
por: Chen, Minghui, et al.
Publicado: (2020)

The Association Between Previous TORCH Infections and Pregnancy and Neonatal Outcomes in IVF/ICSI-ET: A Retrospective Cohort Study
por: Liu, Yifeng, et al.
Publicado: (2020)

The clinical value of progestin-primed ovarian stimulation protocol for women with diminished ovarian reserve undergoing IVF/ICSI: a systematic review and meta-analysis
por: Lin, Guangyao, et al.
Publicado: (2023)

Impact of the number of previous embryo implantation failures on IVF/ICSI-ET pregnancy outcomes in patients younger than 40 years: a retrospective cohort study
por: Fang, Yuan, et al.
Publicado: (2023)

Serum Anti-Müllerian Hormone Is Significantly Altered by Downregulation With Daily Gonadotropin-Releasing Hormone Agonist: A Prospective Cohort Study
por: Drakopoulos, Panagiotis, et al.
Publicado: (2019)

Analysis of IVF/ICSI-FET Outcomes in Women With Advanced Endometriosis: Influence on Ovarian Response and Oocyte Competence
por: Li, Anji, et al.
Publicado: (2020)

Comparison of Cumulative Live Birth Rate Between Aged PCOS Women and Controls in IVF/ICSI Cycles
por: Mai, Zhuoyao, et al.
Publicado: (2021)

Inhibin A—A Promising Predictive Parameter for Determination of Final Oocyte Maturation in Ovarian Stimulation for IVF/ICSI
por: Lawrenz, Barbara, et al.
Publicado: (2020)

Seasonal dynamic of cholecalciferol (D3) and anti-Muellerian hormone (AMH) with impact on ovarian response and IVF/ICSI
por: Rogenhofer, Nina, et al.
Publicado: (2022)

Serum anti-Müllerian hormone levels as a predictor of the ovarian response and IVF outcomes
por: Choi, Min Hye, et al.
Publicado: (2011)

IVF outcomes of women with discrepancies between age and serum anti-Müllerian hormone levels
por: Zhang, Bingqian, et al.
Publicado: (2019)

Are age and anti-Müllerian hormone good predictors of ovarian reserve and response in women undergoing IVF?
por: Scheffer, Juliano Augusto Brum, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_98sjlj5gnrmr38avuju7r8bohi